Despite a 25% share-value drop for the year, Pulike Biologic...
Despite a 25% share-value drop for the year, Pulike Biological Engineering's overall gain of 14% p.a over half a decade along with its consistent growth trend, commands market respect. Current sell-off could be a potential opportunity if the trend continues.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000024976eb169a1d2.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment